학술논문
Safety and efficacy of mitapivat, an oral pyruvate kinase activator, in sickle cell disease: A phase 2, open-label study
Document Type
Letter
Author
Source
In: American Journal of Hematology . (American Journal of Hematology, July 2022, 97(7):E226-E229)
Subject
Language
English
ISSN
10968652
03618609
03618609